Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03875716 · ClinicalTrials.gov registry record · NA

Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma

A NA study of Head and Neck Cancer, sponsored by Dana-Farber Cancer Institute.

Recruiting
Registry status
NA
Development phase
111
Enrollment target
1
Study location

NCT03875716 is a NA study of Head and Neck Cancer that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 111 participants, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03875716, a NA study of Head and Neck Cancer, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.

RECRUITING
Registry status
NA
Development phase
111 participants
Enrollment target
1
Study location

Study Summary

This research study is studying lowering the standard dose of radiation and chemotherapy after surgery, to minimize the side effects and improve the quality of life.

Conditions Studied

Head and Neck Cancer

Interventions

  • RADIATION Radiation therapy

Study Locations (1)

Massachusetts

  • Dana Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 111 participants
Start Date 2019-05-20
Est. Completion 2029-12-31
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03875716

The ClinicalTrials.gov registry entry for NCT03875716 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (57% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which Radiation therapy is the first listed.

NCT03875716 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03875716 about?

NCT03875716 is a clinical study titled "Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma". This research study is studying lowering the standard dose of radiation and chemotherapy after surgery, to minimize the side effects and improve the quality of life.

What is the current status of trial NCT03875716?

This trial is currently recruiting. It is a NA study. The enrollment target is 111 participants. The study started on 2019-05-20. Estimated completion is 2029-12-31.

What conditions does trial NCT03875716 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT03875716?

The interventions under investigation include: Radiation therapy (RADIATION).

Who is sponsoring clinical trial NCT03875716?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03875716 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Head and Neck Cancer

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.